本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

14.30
-0.5500-3.70%
成交量:48.54萬
成交額:698.14萬
市值:15.06億
市盈率:-9.22
高:14.86
開:14.86
低:14.21
收:14.85
52周最高:38.12
52周最低:10.60
股本:1.05億
流通股本:6,053.37萬
量比:0.82
換手率:0.80%
股息:- -
股息率:- -
每股收益(TTM):-1.5508
每股收益(LYR):-1.4480
淨資產收益率:-27.41%
總資產收益率:-19.06%
市淨率:2.56
市盈率(LYR):-9.88

資料載入中...

2022/09/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/14

重要事件披露

8-K - Current report
2022/09/13

重要事件披露

8-K - Current report
2022/08/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/24

重要事件披露

8-K - Current report
2022/05/11

重要事件披露

8-K - Current report
2022/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/03

SEC問詢函

CORRESP [Cover] - Correspondence
2022/02/24

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/24

重要事件披露

8-K - Current report
2022/02/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals